Metastasis: cancer cell’s escape from oxidative stress

Abstract

According to a "canonical" view, reactive oxygen species (ROS) positively contribute, in different ways, to carcinogenesis and to malignant progression of tumor cells: they drive genomic damage and genetic instability, transduce, as signaling intermediates, mitogenic and survival inputs by growth factor receptors and adhesion molecules, promote cell motility and shape the tumor microenvironment by inducing inflammation/repair and angiogenesis. Chemopreventive and tumor-inhibitory effects of endogenous, diet-derived or supplemented antioxidants largely support this notion. However, emerging lines of evidence indicates that tumor cells also need to defend themselves from oxidative damage in order to survive and successfully spread at distance. This "heresy" has recently received important impulse from studies on the role of antioxidant capacity in cancer stem cells self-renewal and resistance to therapy; additionally, the transforming activity of some oncogenes has been unexpectedly linked to their capacity to maintain elevated intracellular levels of reduced glutathione (GSH), the principal redox buffer. These studies underline the importance of cellular antioxidant capacity in metastasis, as the result of a complex cell program involving enhanced motility and a profound change in energy metabolism. The glycolytic switch (Warburg effect) observed in malignant tissues is triggered by mitochondrial oxidative damage and/or activation of redox-sensitive transcription factors, and results in an increase of cell resistance to oxidants. On the other hand, cytoskeleton rearrangement underlying cell motile and tumor-aggressive behavior use ROS as intermediates and are therefore facilitated by oxidative stress. Along this line of speculation, we suggest that metastasis represents an integrated strategy for cancer cells to avoid oxidative damage and escape excess ROS in the primary tumor site, explaning why redox signaling pathways are often up-regulated in malignancy and metastasis.

Cancer Associated Fibroblasts Exploit Reactive Oxygen Species Through a Proinflammatory Signature Leading to Epithelial Mesenchymal Transition and Stemness

“…Indeed, HIF-1 is stabilized by a redox-dependent pathway, involving inactivation of prolyl hydroxylases, iron-dependent enzymes engaged in degradation of HIFs (20,32). The key role of redox stabilization of HIF-1 has also been underscored by recent data describing that the antitumorigenic effects of NAC and VitC depend on HIF-1 redox stabilization (16).…”

“…Inflammation and oxidative stress have already been linked to cancer progression and claimed as responsible for enhanced malignancy (25,32). Oxidative stress, due to deregulated intracellular reactive oxygen species (ROS) production, has been correlated to PCa carcinogenesis, androgen resistance, anchorage independence, and resistance to anoikis (18,22).…”

A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis

“…In contrast to their toxic effects, ROS can act as critical signaling molecules that promote cell proliferation and deregulated growth of cancer cells (61). Importantly, Mnt-deficient cells can enter the cell cycle more rapidly than normal cells and can eventually become tumorigenic (15)(16)(17)(18).…”

The Bladder Tumor Suppressor Protein TERE1 (UBIAD1)Modulates Cell Cholesterol: Implications for Tumor Progression

“…Evidence links oxidative stress to the invasive phenotype in breast and pancreatic cancer (Silva et al, 2003;Brown and Jessup, 2009;Ishikawa et al, 2010). An inherent corollary to oxidative stress relates to its tolerance and the potentially heightened vulnerability of tumor cells to further increases in ROS levels (Pani et al, 2010). Tumor progression depends on adaptations to maintain an elevated oxidative stress level; however, tumor cells must manage oxidative stress levels below the apoptotic threshold.…”